Achyut Healthcare Share Price

Achyut Healthcare Limited, with its corporate operations in Ahmedabad, functions as a pharmaceutical trading and manufacturing company. The company was incorporated in 1996 and is engaged in the manufacturing and sale of pharmaceutical formulations in India. Achyut Healthcare provides a range of pharmaceutical products in the form of tablets, capsules, oral liquids, and injectables. The company also deals in active pharmaceutical ingredients, pharmaceutical products, and medical devices, with business operations in both domestic and international markets.

Achyut Healthcare share price on NSE and BSE signifies how market participants react to the company‘s operational performance and the overall developments in the pharmaceutical sector. The company’s financial health depends on client demand for pharmaceutical formulations, API trading volumes, product mix, and the performance of its trading operations. Achyut Healthcare stock price is influenced by various factors such as earnings, fluctuations in pharmaceutical raw material prices, regulatory changes in the healthcare sector, and currency exchange rates. In the longer run, strategies such as expanding product portfolios, entering new markets, and deepening client relationships affect the stock market sentiments. All these factors need to be monitored closely to have an idea about the company‘s stock price movements.

Achyut Healthcare live share price provides real time information about the last price traded, bid and ask prices, and volume traded. These indicators represent market activity and liquidity, reflecting investor response to corporate announcements, economic conditions, and sector news. Constant monitoring of the Achyut Healthcare live price helps in observing short term price volatility and shows how a stock moves relative to the broader pharmaceutical index. Furthermore, monitoring Achyut Healthcare stock price movements helps investors understand real time market sentiment, price fluctuations, and trading behaviour. It allows them to evaluate short term performance, and respond to news, quarterly results, or sector trends that may influence the company‘s valuation and overall investment outlook.

Achyut Healthcare Limited Company Fundamentals

a. Company Background

Achyut Healthcare Limited was incorporated in 1996 and is based in Ahmedabad, India. The company is engaged in the manufacturing and trading of pharmaceutical formulations in the forms of tablets, capsules, oral liquids, and injectables. It also deals in active pharmaceutical ingredients, pharmaceutical products, and medical devices. The company operates in the single business segment of pharmaceutical formulations and has business operations in both domestic and international markets. It generates the majority of its revenue from domestic markets. The company offers products including Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, and Cellulose acetate Phthalate.

Financial performance is assessed through standard metrics such as revenue growth, operating margins, and return on equity. Market valuation indicators such as the P/E ratio are used by analysts for comparative assessment within the pharmaceutical sector. Overall fundamentals are influenced by pharmaceutical demand, raw material price fluctuations, and input cost fluctuations including procurement costs.

b. Company Product Lines

• Pharmaceutical Formulations

• Provides tablets, capsules, oral liquids, and injectables in various therapeutic categories.
  • Active Pharmaceutical Ingredients

• Deals in APIs including Azathioprine IP, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Tacrolimus USP, and other pharmaceutical ingredients.
  • Medical Devices

• Supplies Infrared thermometers and other medical devices for healthcare applications.
  • Other Pharmaceutical Products

• Offers Cenzure, Arpimune, Everomimus, Sirolimus, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, and Cellulose acetate Phthalate.

The product portfolio is structured to serve both domestic and international clients across the pharmaceutical and healthcare sectors.

c. Company Revenue Model

• Domestic Sales

• Revenue generated through pharmaceutical formulations and API trading with Indian clients across healthcare and pharmaceutical sectors.
  • Export Sales

• Contribution from international clients in various export markets.
  • Institutional and Bulk Contracts

• Supply agreements with healthcare institutions, pharmaceutical companies, and medical device distributors.

Revenue performance is primarily influenced by pharmaceutical demand, pricing realizations, and procurement costs in domestic and export markets.

d. Geographic Presence

• Registered Office

• Administrative and management functions based in Ahmedabad, Gujarat, India.
  • Primary Markets

• Service delivery and trading operations across India.
  • Export Markets

• Products and services are supplied to international markets depending on demand conditions.
  • Distribution Network

• Domestic presence covering various regions in India with export capabilities to international markets.

e. Key Milestones

• 1996 – Incorporation: Achyut Healthcare Limited was incorporated as a pharmaceutical trading and manufacturing company.
• 2021 – Public Listing: The company was listed on the Bombay Stock Exchange with scrip code 543499.
• 2024-2025 – Business Expansion: The company continued expanding its pharmaceutical product portfolio and market presence.

f. Industry Perspective

The pharmaceutical trading and formulations industry is closely linked to demand from healthcare institutions and pharmaceutical companies. Demand trends are influenced by economic activity, healthcare spending, and growth in pharmaceutical consumption driven by population growth and healthcare awareness. The industry is also affected by fluctuations in raw material prices, along with regulatory compliance and quality standards. Companies in the sector must manage regulatory changes and operational efficiency while maintaining product quality. These factors collectively influence financial performance and investor perception of firms like Achyut Healthcare.

Achyut HealthcareLimited Stock Market Presence: Listings & Index Representation

Achyut Healthcare Limited is listed on the Bombay Stock Exchange with the scrip code 543499. Achyut Healthcare share price is actively traded on the BSE. The company ‘s market presence is within the small-cap segment of the market. Due to its sector focus, Achyut Healthcare share price is generally tracked by investors interested in the pharmaceutical trading and formulations industry.

Achyut Healthcare Limited is part of several broad-based and sector-specific stock market indices, reflecting its position as a small-cap pharmaceutical company in India. It is a constituent of indices including the BSE Smallcap and various pharmaceutical sector indices. Achyut Healthcare finds representation in these indices based on its market standing. This presence helps investors track the stock relative to other pharmaceutical and healthcare companies. Achyut Healthcare stock price is monitored by investors as a player in the pharmaceutical trading and formulations space.

Achyut HealthcareLimited Stock Performance and Share Price History

Achyut Healthcare share price today on the BSE reflects its position as a pharmaceutical trading company in India. Its performance is qualitatively driven by factors such as trading volumes, management of procurement costs, growth in pharmaceutical product revenues, and the ability to maintain client relationships. Investors compare Achyut Healthcare movement with other pharmaceutical companies to assess relative strength.

These underlying factors become visible through real market movements across different time periods. Similar trends appear during earnings driven price changes. Broader sector strength has also supported Achyut Healthcare at certain times. Beyond operational and sector influences, corporate actions such as the company ‘s strategic initiatives can significantly affect share price movements by shaping future growth expectations. This shows how strategic initiatives may trigger short term swings, even within a regulatory environment influenced by pharmaceutical demand cycles and client procurement patterns.

While short term movements respond to events and announcements, longer term valuation trends are better captured by Achyut Healthcare annual high and low levels, offering context beyond daily or weekly changes. A notable peak indicates stronger pharmaceutical demand and stable margins, whereas a significant low aligns with market corrections or sector volatility. These extremes reflect the impact of economic conditions, raw material price fluctuations, and earnings visibility, providing a framework for understanding historical performance. Achyut Healthcare share price has shown movement within its 52-week range.

Achyut Healthcare behaviour mirrors the trading patterns of a small-cap pharmaceutical company within India ‘s healthcare ecosystem. The company’s diversified product portfolio spanning pharmaceutical formulations, APIs, and medical devices has shaped its price history. Over the past several years, Achyut Healthcare has experienced periods of sharp gains followed by phases of consolidation. Achyut Healthcare has shown higher volatility compared to larger pharmaceutical companies, reflecting the nature of its smaller-scale operations.

The company’s performance has closely tracked pharmaceutical demand and healthcare spending cycles. Positive momentum appeared during periods of strong pharmaceutical consumption. However, periods of weak healthcare spending and intensified competition have led to consolidation in Achyut Healthcare share price. Achyut Healthcare share price faced selling pressure when revenue growth showed signs of deceleration, reflecting structural shifts in how clients demand pharmaceutical products with competitive pricing.

Despite macroeconomic disruptions, Achyut Healthcare share price showed resilience during the pandemic recovery phase. While the broader pharmaceutical sector faced supply chain challenges, the company’s diversified product portfolio and trading network helped Achyut Healthcare share price recover from pandemic lows. The company maintains relationships with suppliers and continues to invest in product portfolio expansion.

Achyut Healthcare share price has declined for several recurring reasons. A drop in pharmaceutical demand or lower procurement volumes directly impacts revenue visibility and leads to selling pressure. Changes in government policy on pharmaceutical pricing or import regulations can also cause Achyut Healthcare share price to fall. Moreover, increases in procurement costs such as raw material prices without matching pricing power squeeze margins, making Achyut Healthcare share price less attractive. Periods of economic slowdown that affect healthcare spending raise concerns about revenue pipelines, leading to price declines. Achyut Healthcare share price is sensitive to raw material price fluctuations. Broader market sell offs in small cap stocks also pull the price down, regardless of the company ‘s individual performance. Lower client retention or reduced trading volumes directly hurts revenue, resulting in a lower valuation.

Achyut Healthcare has seen downward pressure when the company reported fluctuations in net profit margins. Achyut Healthcare movements often mirror the broader pharmaceutical sector trends. Achyut Healthcare can be impacted by changes in pharmaceutical demand and client retention rates. Achyut Healthcare stock price has historically shown sensitivity to regulatory changes. Achyut Healthcare stock price may also be affected by the company’s ability to maintain its competitive edge in pharmaceutical trading. Achyut Healthcare stock price performance is closely watched by investors tracking the small-cap pharmaceutical segment. Achyut Healthcare stock price has moved within a 52-week range that reflects broader market conditions in pharmaceutical stocks.

Achyut HealthcareLimited Investor Relevance and Role in Portfolio

Achyut Healthcare Limited is a holding in small cap and pharmaceutical sector portfolios, offering exposure to pharmaceutical trading, formulations, and healthcare products. Its inclusion in sector indices underscores its importance in India‘s pharmaceutical and healthcare space. The company’s position as a pharmaceutical trading company, together with its expanding product portfolio and diversified presence, makes it a consideration for long term allocations.

Achyut Healthcare share price is influenced by the company‘s ownership structure. Achyut Healthcare’s equity is held by a broad mix of promoters, institutional investors, and retail investors, reflecting its standing in India‘s pharmaceutical sector. Promoters hold a significant stake in the company, reflecting strong internal control. Institutional investors and the public hold the remaining stake. The company’s management includes key executive personnel who oversee operations. This investor base, with stable promoter participation, underscores the company‘s role as a holding in both domestic and international portfolios concentrating on pharmaceutical trading.

Beyond fundamentals and ownership, Achyut Healthcare share price is actively monitored in cash market segments, where trading volumes and delivery patterns reflect expectations on pharmaceutical demand, procurement costs, and regulatory policy actions. Achyut Healthcare stock price is available for trading on the Bombay Stock Exchange, allowing investors to take positions based on their outlook for the pharmaceutical sector. Market participants watch these trading indicators to gauge sentiment around quarterly results and policy announcements.

Technical indicators provide additional insight into short term momentum shifts in Achyut Healthcare share price. While these indicators are primarily used for near term trading decisions, they also help investors and portfolio managers understand broader market sentiment and anticipate potential volatility, especially around key events or announcements. In the short term and weekly timeframe, the stock has exhibited price movements that correlate with broader pharmaceutical sector trends. Based on available data, the stock‘s beta indicates higher volatility compared to the broader market.

Overall, Achyut Healthcare demonstrates a higher volatility profile compared to the broader market, with the stock generally considered to have elevated systematic risk. This makes it more sensitive to broader market movements compared to larger pharmaceutical companies, and it remains exposed to sector specific factors such as pharmaceutical demand and raw material price fluctuations.

Achyut HealthcareLimited Sectoral Relevance and Peer Positioning

Achyut Healthcare Limited sector relevance stems from its presence in the pharmaceutical trading and formulations industry, its position as a pharmaceutical company serving domestic and international markets, its portfolio covering pharmaceutical formulations, APIs, and medical devices, its product offerings in the form of tablets, capsules, oral liquids, and injectables, and its focus on dealing in pharmaceutical products based on customer requirements, establishing it as a focused small-cap pharmaceutical provider. Peer comparisons with companies like Sun Pharmaceutical Industries, Dr. Reddy‘s Laboratories, Cipla, Lupin, and Aurobindo Pharma focus on revenue growth, margin performance, product portfolio expansion, and trading scale rather than short term stock moves. These benchmarks help investors assess operational scale, efficiency, and regulatory adherence. Institutional tracking of pharmaceutical demand, healthcare trends, and pricing policies further highlights Achyut Healthcare positioning within the broader Indian pharmaceutical market.

Achyut Healthcare market cap highlights its position as a small-cap player within the pharmaceutical trading sector. The company’s market capitalization has moved in line with investor perceptions of the company‘s growth potential following its strategic initiatives. From earlier periods through more recent times, the market cap showed an increasing trend as the company expanded its pharmaceutical product portfolio. This pattern reflects investor confidence during favourable healthcare spending cycles, followed by consolidation during challenging periods impacted by macroeconomic headwinds. This decrease mirrors the correction in Achyut Healthcare share price from its highs to recent levels.

Achyut Healthcare earnings trajectory demonstrates the impact of its operational execution in a competitive industry. In recent fiscal years, total income showed trends supported by the core pharmaceutical trading and formulations business. The company’s revenue from operations showed movement, supported by trading volumes across pharmaceutical products. Total income showed corresponding movement over the same period. Profit after tax showed improvement at certain periods, demonstrating operational efficiency. However, revenue growth faced challenges from fluctuating raw material prices, intensified competition, and reduced healthcare spending in certain geographies. However, the company has expanded its product portfolio and continues to invest in pharmaceutical capabilities. These developments illustrate the evolving nature of the pharmaceutical trading industry and the company‘s position within this sector.

Achyut Healthcare EPS provides insight into its operational performance and income generation from pharmaceutical trading and formulations. The company reported earnings that varied based on pharmaceutical cycles and client spending patterns. The earnings per share has shown movement over time. The company has a face value per share and is promoted by its founding promoters. More recent quarterly performance suggests that EPS has shown movement as the company benefits from operational efficiency.

Achyut Healthcare P/E ratio reflects how investors perceive the company’s earnings relative to its revenue streams from pharmaceutical trading. The current valuation compared to industry averages indicates how the market assesses the company‘s earnings potential. The company’s profit after tax has shown movement across recent fiscal periods based on operational performance. Overall, these changes highlight how market sentiment evolved alongside the company‘s operational performance in a dynamic industry.

Summary

Achyut Healthcare Limited operates in the pharmaceutical trading and formulations space, providing pharmaceutical products, APIs, and medical devices to domestic and international markets. The company has a presence in the pharmaceutical sector and continues to serve healthcare institutions and pharmaceutical companies. Achyut Healthcare share price reflects market sentiment towards the company’s performance. The company‘s fundamentals are influenced by pharmaceutical demand, raw material prices, and operational efficiency.